日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness

在健康志愿者中开展的 1 期研究旨在探讨 VIR-2482 的安全性、耐受性和药代动力学:一种用于预防严重甲型流感疾病的单克隆抗体

David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

肌注与静脉注射SARS-CoV-2中和抗体Sotrovimab治疗COVID-19的疗效比较(COMET-TAIL):一项随机非劣效性临床试验

Shapiro, Adrienne E; Sarkis, Elias; Acloque, Jude; Free, Almena; Gonzalez-Rojas, Yaneicy; Hussain, Rubaba; Juarez, Erick; Moya, Jaynier; Parikh, Naval; Inman, David; Cebrik, Deborah; Nader, Ahmed; Noormohamed, Nadia; Wang, Qianwen; Skingsley, Andrew; Austin, Daren; Peppercorn, Amanda; Agostini, Maria L; Parra, Sergio; Chow, Sophia; Mogalian, Erik; Pang, Phillip S; Hong, David K; Sager, Jennifer E; Yeh, Wendy W; Alexander, Elizabeth L; Gaffney, Leah A; Kohli, Anita

Population pharmacokinetics and exposure-response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID-19

早期治疗轻度至中度 COVID-19 患者时单剂量 sotrovib 的群体药代动力学和暴露-反应分析

Sager, Jennifer E; El-Zailik, Asma; Passarell, Julie; Roepcke, Stefan; Li, Xiaobin; Aldinger, Melissa; Nader, Ahmed; Skingsley, Andrew; Alexander, Elizabeth L; Yeh, Wendy W; Mogalian, Erik; Garner, Chad; Peppercorn, Amanda; Shapiro, Adrienne E; Reyes, Maribel

Antibody therapy reverses biological signatures of COVID-19 progression

抗体疗法逆转 COVID-19 进展的生物学特征

Maher, M Cyrus; Soriaga, Leah B; Gupta, Anil; Chen, Yi-Pei; di Iulio, Julia; Ledoux, Sarah; Smithey, Megan J; Cathcart, Andrea L; McKusick, Kathleen; Sun, David; Aldinger, Melissa; Alexander, Elizabeth; Purcell, Lisa; Ding, Xiao; Peppercorn, Amanda; Austin, Daren; Mogalian, Erik; Yeh, Wendy W; Shapiro, Adrienne E; Corti, Davide; Virgin, Herbert W; Pang, Phillip S; Telenti, Amalio

Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection

VIR-2218(一种靶向HBV感染的RNAi疗法)的临床和临床前单剂量药代动力学研究

Gupta, Sneha V; Fanget, Marie C; MacLauchlin, Christopher; Clausen, Valerie A; Li, Jing; Cloutier, Daniel; Shen, Ling; Robbie, Gabriel J; Mogalian, Erik

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

索非布韦和维帕他韦治疗合并1型人类免疫缺陷病毒感染的丙型肝炎病毒感染患者:一项开放标签的3期研究

Wyles, David; Bräu, Norbert; Kottilil, Shyam; Daar, Eric S; Ruane, Peter; Workowski, Kimberly; Luetkemeyer, Anne; Adeyemi, Oluwatoyin; Kim, Arthur Y; Doehle, Brian; Huang, K C; Mogalian, Erik; Osinusi, Anu; McNally, John; Brainard, Diana M; McHutchison, John G; Naggie, Susanna; Sulkowski, Mark

Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects

Velpatasvir(一种泛基因型丙型肝炎病毒NS5A抑制剂)在健康受试者中的临床前药代动力学和首次人体药代动力学、安全性和耐受性研究

Mogalian, Erik; German, Polina; Kearney, Brian P; Yang, Cheng Yong; Brainard, Diana; Link, John; McNally, John; Han, LingLing; Ling, John; Mathias, Anita

Inhalation of an ethanol-based zileuton formulation provides a reduction of pulmonary adenomas in the A/J mouse model

吸入乙醇基齐留通制剂可减少A/J小鼠模型中的肺腺瘤。

Karlage, Kelly L; Mogalian, Erik; Jensen, Annikka; Myrdal, Paul B